Clinical Trial Update: Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial update evaluating itraconazole for histoplasmosis, sporotrichosis, and blastomycosis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blastomycosis
• Histoplasmosis
• Sporotrichosis

Drugs mentioned

• Itraconazole (Itraconazole)

Snippet

Sponsor: National Center for Research Resources (NCRR) | Conditions: Histoplasmosis, Sporotrichosis | Phase 1, Phase 2 | Status: COMPLETED